Genetic diversity of HPV35 in Chad and the Central African Republic, two landlocked countries of Central Africa: A cross-sectional study

PLoS One. 2024 Jan 25;19(1):e0297054. doi: 10.1371/journal.pone.0297054. eCollection 2024.

Abstract

Human Papillomavirus (HPV)-35 accounts for up 10% of cervical cancers in Sub-Saharan Africa. We herein assessed the genetic diversity of HPV35 in HIV-negative women from Chad (identified as #CHAD) and HIV-infected men having sex with men (MSM) in the Central African Republic (CAR), identified as #CAR. Ten HPV35 DNA from self-collected genital secretions (n = 5) and anal margin samples (n = 5) obtained from women and MSM, respectively, were sequenced using the ABI PRISM® BigDye Sequencing technology. All but one HPV35 strains belonged to the A2 sublineage, and only #CAR5 belonged to A1. HPV35 from #CAR had higher L1 variability compared to #CHAD (mean number of mutations: 16 versus 6). L1 of #CAR5 showed a significant variability (2.29%), suggesting a possible intra-type divergence from HPV35H. Three (BC, DE, and EF) out of the 5 capsid loops domains remained totally conserved, while FG- and HI- loops of #CAR exhibited amino acid variations. #CAR5 also showed the highest LCR variability with a 16bp insertion at binding sites of the YY1. HPV35 from #CHAD exhibited the highest variability in E2 gene (P<0.05). E6 and E7 oncoproteins remained well conserved. There is a relative maintenance of a well conserved HPV35 A2 sublineage within heterosexual women in Chad and MSM with HIV in the Central African Republic.

MeSH terms

  • Alphapapillomavirus*
  • Central African Republic
  • Cross-Sectional Studies
  • Female
  • Genetic Variation
  • HIV Infections* / epidemiology
  • Homosexuality, Male
  • Human Papillomavirus Viruses*
  • Humans
  • Male
  • Papillomaviridae / genetics
  • Papillomavirus Infections* / epidemiology
  • Sexual and Gender Minorities*

Supplementary concepts

  • human papillomavirus 35

Grants and funding

The author(s) received no specific funding for this work.